7th Annual Molecular Diagnostics Europe
地点:葡萄牙,里斯本,Lisbon Marriott Hotel
Choose your language

关于Molecular Diagnostics Europe

Cambridge Healthtech Institute (CHI) 主办的第7届International Molecular Diagnostics Europe、将在2019年5月6日至9日、在葡萄牙里斯本的Lisbon Marriott Hotel举行。本届会场规模更胜以往,在大学及药厂致力于诊断法开发的研究人员可与药品及医疗相关部门的终端用户建立链接,提出分子诊断相关综合观点,除了产前诊断、肿瘤治疗、传染病、定点照护、液态切片之外,更新增了对应免疫疗法的生物标记、癌症免疫疗法的伴随诊断等主题的演讲。本学会聚焦于近年备受注目的分子诊断领域,为了学习影响未来医疗服务及药物研究的新技术、平台及应用,将有超过400位与会者参加。请勿错过2019年春天举行的,针对诊断疗法主题的重要活动。


Extending the Scope of Prenatal Diagnosis for Monogenic Disorders: Non-Invasive Prenatal Diagnosis
Lyn Chitty, PhD, MBBS, MRCOG, Great Ormond Street Hospital for Children NHS Foundation Trust

An Overview on the Emergence of Arbovirus Epidemics in the World and Their Consequences
Pedro Fernando da Costa Vasconcelos, MD, PhD, Ministry of Health

The Evidence Base for Circulating Tumour DNA Blood-Based Biomarkers for the Early Detection of Cancer: A Systematic Mapping Review
Jacqui Shaw, PhD, University of Leicester

Multi-Step Real-Time PCR Coupled with HRM Enables Rapid Mutation Assessment Prior to Targeted Re-Sequencing
G. Mike Makrigiorgos, PhD, Dana Farber and Harvard Medical School

Upcoming New Diagnostic Regulations and How They Will Impact Developers of AMR POC Tests
Doris-Ann Williams, MBE, British In Vitro Diagnostics Association (BIVDA)

Phenogenomic Subtyping of CTCs to Identify Biomarkers that Improve Prostate Cancer Patient Outcomes
Howard I. Scher, MD, Memorial Sloan Kettering Cancer Center